Tag: tumor microenvironment modulation

Hepatocellular carcinoma, the most common primary cancer of the liver, has become a major testing ground for immunotherapy. Drugs that ...

Head and neck squamous cell carcinoma (HNSCC) is among the world’s most challenging cancers, accounting for approximately 90% of malignancies ...

Lung cancer’s spread to bone is one of the most destructive stages of the disease, often causing severe pain, fractures, ...

Immune checkpoint blockade has reshaped modern oncology, but its success remains uneven. Drugs that disrupt the PD-1/PD-L1 pathway can produce ...

Pancreatic cancer may be one of the most difficult cancers to treat, but new research points to a microscopic event ...

A new early-stage clinical study reports that targeting tumor metabolism and immune recognition may offer a workable strategy for patients ...

A new viral-science report highlights fresh evidence that directly targeting oncogenic KRAS can prime the immune system to fight pancreatic ...

A new open-access Review in Ferroptosis and Oxidative Stress spotlights Z-nucleic acid-binding protein 1 (ZBP1), framing it as an emerging ...

A breakthrough in cancer immunotherapy has emerged from a research team led by Professor Yoosoo Yang at Sungkyunkwan University, in ...

Reston, VA (June 5, 2026) — Groundbreaking advancements in nuclear medicine and molecular imaging have been unveiled in a series ...